Key facts
- This page summarizes Mark Strobeck's Form 3 filing for ROCKWELL MEDICAL, INC. (RMTI).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jul 2022, 16:33.
Mark Strobeck - 01 Jul 2022 Form 3 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- RMTI
- Reported as of
- 01 Jul 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Jul 2022, 16:33:09 UTC
- Next SEC filing
- 21 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Megan Timmins, Attorney-in-Fact for Mark Strobeck
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Strobeck filed Form 3 for ROCKWELL MEDICAL, INC. (RMTI) on 05 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Ex. 24 - Power of Attorney